Publication | Closed Access

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

Metabolic SyndromeOpen-label TrialDiabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2PharmacotherapyDiabetes MellitusMedicineLiraglutide Versus SitagliptinHealth Sciences